Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy

Renal Failure

Volumn 35, Issue 6, 2013, Pages 906-910

  Bilge, Ugur ^a   Sahin, Garip ^a   Unluoglu, Ilhami ^a   Ipek, Muhterem ^a   Durdu, Murat ^a   Keskin, Ahmet ^b  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b Department of Anesthesiology and Reanimation   (Turkey)

Author keywords

Chronic kidney disease; Inappropriate drug use; Nonsteroidal anti inflammatory drugs

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DRUG MISUSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 84879027664     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.801272     Document Type: Article

References (32)

1. Willlams CM. Using medications appropriately in older adults. Am Fam Physician. 2002;66(10):1917-1924
2. Tanrverdi MH, Karadaǧ A, Hatipoglu ES. Chronic kidney failure. Konuralp Med J. 2010;2(2):27-32
3. Serdengeçti K, Suleymanlar G, Altparmak M, et al. The Turkish Society of Nephrology Registry of Nephrology, Dialysis and Transplantation in Turkey, Registry 2010. Available at: Http:// www.tsn.org.tr/folders/file/2010- registry.pdf. Accessed December 16, 2012
4. Johnson CA, Levey AS, Coresh J, et al. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004;70(5):869-876 (Pubitemid 39201438)
5. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: Renoprotective benefits of renin-Angiotensin system inhibition. Ann Intern Med. 2002;136:604-615 (Pubitemid 34407045)
6. McClellan WM, Knight DF, Karp H, et al. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines. Am J Kidney Dis. 1997;29:368-375 (Pubitemid 27106558)
7. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12 (Pubitemid 36043346)
8. Blix HS, Viktil KK, Moger TA, et al. Use of renal risk drugs in hospitalized patients with impaired renal function-An underestimated problem? Nephrol Dial Transplant. 2006; 21(11):3164-3171 (Pubitemid 44567089)
9. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139: 137-147
10. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal antiinflammatory drugs and the risk for chronic renal disease. Ann Intern Med. 1991; 115:165-172
11. Rothberg MB, Kehoe ED, Courtemanche AL, et al. Recognition and management of chronic kidney disease in an elderly ambulatory population. J Gen Intern Med. 2008; 23(8):1125-1130
12. Kitchen J, Kane D. Non-steroidal anti-inflammatory drug prescriptions in hospital inpatients: Are we assessing the riskš Ir J Med Sci. 2010;179(3):357-360
13. Plantinga L, Grubbs V, Sarkar U, et al CDC CKD Surveillance Team. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med. 2011;9(5):423-430
14. Pillans PI, Landsberg PG, Fleming AM, et al. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J. 2003; 33:10-13 (Pubitemid 36241568)
15. Salomon L, Deray G, Jaudon MC, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15:331-335 (Pubitemid 36987271)
16. Cantu TG, Ellerbeck EF, Yun SW, et al. Drug prescribing for patients with changing renal function. Am J Hosp Pharm. 1992;49: 2944-2948
17. Breton G, Froissart M, Janus N, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function-The Three-City population-based study. Nephrol Dial Transplant. 2011;26(9):2852-2859
18. Cockroft DW, Gault MH. Prediction of creatinine clearence from serum creatinine. Nephron. 1976;16:31-41
19. Levey A, Bosch J, Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130(6): 461-470 (Pubitemid 29135798)
20. National Kidney Fundation (NKF). K/DOQI Clinical Practice Guidlines for Chronic Kidney Disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1-S266
21. Papaioannou A, Clarke JA, Campbell G, et al. Assessment of adherence to renal dosing guidelines in long-Term care facilities. J Am Geriatr Soc. 2000;48:1470-1473
22. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011; 171(11):1013-1019
23. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med. 1991;115(3):165-172
24. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331(25):1675-1679 (Pubitemid 24373619)
25. Goroll AH, Mulley AG Jr, eds. Primary Care Medicine: Office Evaluation and Management of the Adult Patient. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009
26. Fauci AS, ed. Harrison's Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill Medical; 2008
27. Clinical K/DOQI Practice Guidelines-Clinical Practice Guidelines For Chronic Kidney Disease: Evaluation, Classification and Stratification. 2002 National Kidney Foundation, Inc. Available at: Http://www.kidney.org/ professionals/kdoqi/pdf/ckd-evaluation- classification
28. Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16: 763-773 (Pubitemid 41725113)
29. Spruill WJ, Wade WE, Cobb 3rd HH. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function. Am J Geriatr Pharmacother. 2008;6: 153-160
30. Kays MB, Overholser BR, Mueller BA, et al. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin. Am J Kidney Dis. 2003;42:1253-1259 (Pubitemid 37486770)
31. How PP, Fischer JH, Arruda JA, et al. Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin. Clin J Am Soc Nephrol. 2007;2:1235-1240
32. Hur E, Duman E, Bozkurt D, et al. Non steroidal antiinflammatory drugs may be harmful to normal kidneys: Experimental surgery model. Hippokratia. 2012;16(2):160-165